✓Strengths
- Low debt: debt-to-equity of -38.8.
- Return on equity is healthy at 515.8%.
- Return on capital employed is healthy at 1,022%.
!Watch-points
- Thin interest cover: operating profit covers interest only about -1.3 times.
- The company reported a net loss in the latest period.
- Current ratio of 0.94 is below 1, so current liabilities exceed current assets.
- Sales growth has been slow over five years (about -36% a year).
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreDistress zone
-1.01
In Altman’s study, scores in this range were associated with a higher incidence of financial distress.
Computed without the market-value term.
Piotroski F-ScoreWeak
3 / 5
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 5 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Book Value₩ -54.51
ROCE1022.04%
ROE515.76%
Debt to Equity-38.80
Current Ratio0.94
EPS₩ -281.13
PAT Margin-17.00%
ICR-1.29
Compounded Sales Growth
10 Years
—
5 Years
-36.48%
3 Years
—
TTM
—
Compounded Profit Growth
10 Years
—
5 Years
—
3 Years
—
TTM
—
Stock Price CAGR
10 Years
—
5 Years
—
3 Years
—
1 Year
—
Return on Equity
10 Years
—
5 Years
—
3 Years
—
Last Year
515.76%